Funding
← Back to your selection

Safar Partners

Activity from announced rounds

Activity in this selectionSeries B
Rounds participated in
2
Confirmed lead rounds
0
1 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$269M
2 disclosed · full round size, not this investor’s share

By stage

Series B2

By primary sector

Biotech1
Climate tech1

By country

United States2

Rounds

2 in this selection
Soufflé Therapeutics

Soufflé Therapeutics develops targeted RNA medicines for patients with muscle disorders and heart failure.

$135MSeries B
Participant
Quaise Energy

Develops millimeter-wave drilling technology to access superhot geothermal energy resources

$134MSeries B
Role not disclosed